---
title: Biochemistry recall session
videoId: cXdfr9uCjww
---

From: [[marrowmed]] <br/> 

This article summarizes the May 2025 [[high_yield_topics_in_biochemistry_for_inicet | INICET]] biochemistry recall session, offering insights into question types, difficulty levels, and key topics covered <a class="yt-timestamp" data-t="00:00:03">[00:00:03]</a>.

## Session Overview
Approximately 15 questions were from biochemistry in the May 2025 [[high_yield_topics_in_biochemistry_for_inicet | INICET]] exam <a class="yt-timestamp" data-t="00:00:20">[00:00:20]</a>. The difficulty level was moderate to difficult <a class="yt-timestamp" data-t="00:00:25">[00:00:25]</a>.

### Key Topics Covered
The topics most frequently covered included <a class="yt-timestamp" data-t="00:00:30">[00:00:30]</a>:
*   Genetics (3-5 questions) <a class="yt-timestamp" data-t="00:00:32">[00:00:32]</a>
*   Carbohydrates <a class="yt-timestamp" data-t="00:00:37">[00:00:37]</a>
*   Lipids <a class="yt-timestamp" data-t="00:00:37">[00:00:37]</a>
*   Amino acids <a class="yt-timestamp" data-t="00:00:37">[00:00:37]</a>
*   Proteins <a class="yt-timestamp" data-t="00:00:39">[00:00:39]</a>
*   Acid-base balance (1 question) <a class="yt-timestamp" data-t="00:00:41">[00:00:41]</a>

### Question Repetition and Novelty
Only one direct repeat question from previous years was identified, concerning [[metabolic_disorders_in_biochemistry_for_neet_pg_exam | Cori's disease]] <a class="yt-timestamp" data-t="00:00:52">[00:00:52]</a> <a class="yt-timestamp" data-t="00:01:04">[00:01:04]</a>. However, 9 to 10 questions were based on previous year topics <a class="yt-timestamp" data-t="00:00:57">[00:00:57]</a>.

New questions in this [[high_yield_topics_in_biochemistry_for_inicet | INICET]] session included topics like <a class="yt-timestamp" data-t="00:01:07">[00:01:07]</a>:
*   "Eye of tiger sign" <a class="yt-timestamp" data-t="00:01:10">[00:01:10]</a>
*   Gene pool <a class="yt-timestamp" data-t="00:01:13">[00:01:13]</a>
*   Surface plasmon resonance <a class="yt-timestamp" data-t="00:01:15">[00:01:15]</a>
*   Strain typing <a class="yt-timestamp" data-t="00:01:16">[00:01:16]</a>

## Detailed Question Analysis

### Sphingolipidosis Diagnosis (Cherry Red Spot)
A 4-year-old child presented with developmental regression, hepatomegaly, and a cherry red spot; startle reflex was normal <a class="yt-timestamp" data-t="00:01:26">[00:01:26]</a>. The key clue is the presence of a cherry red spot, indicating a sphingolipidosis <a class="yt-timestamp" data-t="00:01:55">[00:01:55]</a> <a class="yt-timestamp" data-t="00:01:59">[00:01:59]</a>.

*   **Approach:** Start with the presence or absence of a cherry red spot and then check for visceromegaly <a class="yt-timestamp" data-t="00:02:25">[00:02:25]</a> <a class="yt-timestamp" data-t="00:02:45">[00:02:45]</a>.
    *   **Cherry red spot present:** Check for visceromegaly <a class="yt-timestamp" data-t="00:02:45">[00:02:45]</a>.
        *   Visceromegaly absent: Tay-Sachs disease (GM2 gangliosidosis), Metachromatic leukodystrophy, Krabbe's disease <a class="yt-timestamp" data-t="00:02:55">[00:02:55]</a>. Krabbe's disease sometimes has a cherry red spot, sometimes not <a class="yt-timestamp" data-t="00:03:36">[00:03:36]</a>.
        *   Visceromegaly present: Niemann-Pick disease or GM1 gangliosidosis <a class="yt-timestamp" data-t="00:03:21">[00:03:21]</a>.
    *   **Cherry red spot absent:** Check for massive visceromegaly <a class="yt-timestamp" data-t="00:03:52">[00:03:52]</a>.
        *   Massive visceromegaly present: Gaucher's disease <a class="yt-timestamp" data-t="00:03:58">[00:03:58]</a> <a class="yt-timestamp" data-t="00:04:01">[00:04:01]</a>.
        *   No massive visceromegaly: Fabry disease (look for additional clues like angiokeratoma) <a class="yt-timestamp" data-t="00:04:08">[00:04:08]</a>.
*   **Case Analysis:** The patient has a cherry red spot and hepatomegaly (visceromegaly) <a class="yt-timestamp" data-t="00:05:05">[00:05:05]</a> <a class="yt-timestamp" data-t="00:05:11">[00:05:11]</a>. This narrows it down to Niemann-Pick disease or GM1 gangliosidosis <a class="yt-timestamp" data-t="00:05:24">[00:05:24]</a>.
    *   Hexosaminidase A deficiency is Tay-Sachs (no visceromegaly) <a class="yt-timestamp" data-t="00:05:38">[00:05:38]</a>.
    *   Sphingomyelinase deficiency is Niemann-Pick disease <a class="yt-timestamp" data-t="00:05:51">[00:05:51]</a>.
    *   Arylsulfatase A deficiency is Metachromatic leukodystrophy (no visceromegaly) <a class="yt-timestamp" data-t="00:05:54">[00:05:54]</a>.
    *   Glucocerebrosidase deficiency is Gaucher's disease (no cherry red spot, though visceromegaly is present) <a class="yt-timestamp" data-t="00:06:04">[00:06:04]</a>.
*   **Answer:** Sphingomyelinase deficiency (Niemann-Pick disease) <a class="yt-timestamp" data-t="00:05:51">[00:05:51]</a>.

### Gene Pool Definition
The question asked what "gene pool" refers to <a class="yt-timestamp" data-t="00:06:45">[00:06:45]</a>.
*   **Definition:** A gene pool is the combination of all genes, including all alleles, present in a reproducing population or species <a class="yt-timestamp" data-t="00:07:41">[00:07:41]</a>. This ensures genetic diversity <a class="yt-timestamp" data-t="00:07:01">[00:07:01]</a> <a class="yt-timestamp" data-t="00:07:52">[00:07:52]</a>.
*   **Reasoning:** If taken from an inbreeding population, genetic diversity would be less <a class="yt-timestamp" data-t="00:07:20">[00:07:20]</a>.
*   **Answer:** Population <a class="yt-timestamp" data-t="00:08:24">[00:08:24]</a>.

### Southern, Northern, Western Blotting
This question asked to identify the correct blotting technique: N R S D WP <a class="yt-timestamp" data-t="00:08:52">[00:08:52]</a>.
*   **Mnemonic:** S (Southern) for D (DNA), N (Northern) for R (RNA), W (Western) for P (Protein) <a class="yt-timestamp" data-t="00:08:48">[00:08:48]</a>.
*   **Answer:** A (N=RNA, S=DNA, W=Protein) <a class="yt-timestamp" data-t="00:08:52">[00:08:52]</a>.

### Glycogen Storage Disorder: Cori's Disease
A neonate developed liver disease, muscle weakness, severe fasting hypoglycemia, hepatomegaly, ketosis, acidosis, and elevated ALT/AST <a class="yt-timestamp" data-t="00:09:00">[00:09:00]</a>. A normal rise in blood glucose was observed after IV glucagon following a carbohydrate meal <a class="yt-timestamp" data-t="00:09:37">[00:09:37]</a>. This was an exact repeat question <a class="yt-timestamp" data-t="00:13:51">[00:13:51]</a>.

*   **Clues for [[metabolic_disorders_in_biochemistry_for_neet_pg_exam | Cori's disease]]:** Fasting hypoglycemia, hepatomegaly, and increased liver enzymes <a class="yt-timestamp" data-t="00:10:28">[00:10:28]</a>.
*   **Distracting clues:** Ketosis and acidosis are typical of Von Gierke's disease (Type I) <a class="yt-timestamp" data-t="00:10:51">[00:10:51]</a>. The glycogen storage might not be explicitly stated as abnormal, which would favor [[metabolic_disorders_in_biochemistry_for_neet_pg_exam | Cori's disease]] <a class="yt-timestamp" data-t="00:11:16">[00:11:16]</a>.
*   **Differentiating Test: IV Glucagon Challenge:**
    *   **During overnight fast:** Cannot differentiate between Von Gierke's and Cori's <a class="yt-timestamp" data-t="00:09:58">[00:09:58]</a>.
    *   **After meals/with meals:**
        *   In Von Gierke's (glucose-6-phosphatase deficiency), glucagon will not raise blood glucose because the final enzyme is absent <a class="yt-timestamp" data-t="00:13:02">[00:13:02]</a>.
        *   In [[metabolic_disorders_in_biochemistry_for_neet_pg_exam | Cori's disease]] (debranching enzyme deficiency), glucagon can still release glucose-1-phosphate from glycogen branches, leading to a rise in blood glucose <a class="yt-timestamp" data-t="00:13:18">[00:13:18]</a> <a class="yt-timestamp" data-t="00:13:22">[00:13:22]</a>.
*   **Answer:** Debranching enzyme (alpha-1,4/1,6-glucosidase) deficiency <a class="yt-timestamp" data-t="00:10:15">[00:10:15]</a> <a class="yt-timestamp" data-t="00:13:49">[00:13:49]</a>.

### PCR Cycles for Half Copies
The question asked how many cycles of PCR are required to generate half the copies of 26 cycles <a class="yt-timestamp" data-t="00:14:10">[00:14:10]</a>.
*   **Formula:** Number of amplicons = 2^n (where n is the number of cycles) <a class="yt-timestamp" data-t="00:14:21">[00:14:21]</a>.
*   **Calculation:** If x = 2^n, then x/2 = 2^n / 2 = 2^(n-1) <a class="yt-timestamp" data-t="00:14:48">[00:14:48]</a>.
*   **Answer:** If the target is 26 cycles, half the copies are produced at 26 - 1 = 25 cycles <a class="yt-timestamp" data-t="00:15:18">[00:15:18]</a> <a class="yt-timestamp" data-t="00:16:29">[00:16:29]</a>.

### Enzymes in Weight Gain from High Carbohydrate Diet
An obese individual on a high carbohydrate diet <a class="yt-timestamp" data-t="00:16:33">[00:16:33]</a>. The question asked which enzymes are most responsible for weight gain (multiple response) <a class="yt-timestamp" data-t="00:16:42">[00:16:42]</a>.

*   **Process:**
    1.  High carbohydrate diet leads to excess glucose <a class="yt-timestamp" data-t="00:16:55">[00:16:55]</a>.
    2.  Excess glucose undergoes glycolysis to pyruvate <a class="yt-timestamp" data-t="00:17:05">[00:17:05]</a>.
    3.  Pyruvate enters mitochondria and is irreversibly converted to acetyl-CoA by pyruvate dehydrogenase <a class="yt-timestamp" data-t="00:17:08">[00:17:08]</a> <a class="yt-timestamp" data-t="00:17:14">[00:17:14]</a>.
    4.  Acetyl-CoA needs to be transported to the cytoplasm for fatty acid synthesis, so it's transported as citrate via the tricarboxylic acid transporter <a class="yt-timestamp" data-t="00:17:52">[00:17:52]</a> <a class="yt-timestamp" data-t="00:18:02">[00:18:02]</a>.
    5.  In the cytoplasm, acetyl-CoA is converted to malonyl-CoA by acetyl-CoA carboxylase, which is the rate-limiting enzyme of fatty acid synthesis <a class="yt-timestamp" data-t="00:18:19">[00:18:19]</a> <a class="yt-timestamp" data-t="00:18:41">[00:18:41]</a>.
    6.  Malonyl-CoA also inhibits fatty acid oxidation by blocking CPT1 (carnitine palmitoyltransferase 1), the gateway for beta-oxidation <a class="yt-timestamp" data-t="00:18:59">[00:18:59]</a>.
*   **Responsible Enzymes/Molecules:**
    *   Malonyl-CoA <a class="yt-timestamp" data-t="00:19:26">[00:19:26]</a>
    *   Acetyl-CoA carboxylase <a class="yt-timestamp" data-t="00:19:30">[00:19:30]</a>
    *   Tricarboxylate transporter <a class="yt-timestamp" data-t="00:19:48">[00:19:48]</a>
*   **Note:** If single response, acetyl-CoA carboxylase would be the best answer as it's the rate-limiting enzyme <a class="yt-timestamp" data-t="00:20:32">[00:20:32]</a>. Pyruvate dehydrogenase would also be a strong contender for its role in diverting carbohydrates to acetyl-CoA <a class="yt-timestamp" data-t="00:20:55">[00:20:55]</a>.
*   **Answer:** Malonyl-CoA, Acetyl-CoA carboxylase, and Tricarboxylate transporter <a class="yt-timestamp" data-t="00:19:55">[00:19:55]</a>.

### G6PD Deficiency and Bilirubin Findings
A question on G6PD deficiency asked about bilirubin findings <a class="yt-timestamp" data-t="00:22:04">[00:22:04]</a>.
*   **Mechanism:** G6PD deficiency leads to decreased NADPH, which promotes hemolysis <a class="yt-timestamp" data-t="00:22:26">[00:22:26]</a> <a class="yt-timestamp" data-t="00:22:30">[00:22:30]</a>. This results in hemolytic jaundice <a class="yt-timestamp" data-t="00:22:38">[00:22:38]</a>.
*   **Bilirubin Profile:** In hemolytic jaundice, indirect (unconjugated) bilirubin is elevated, and direct (conjugated) bilirubin is normal <a class="yt-timestamp" data-t="00:22:48">[00:22:48]</a>.
*   **Urobilinogen:** Excess hemolysis leads to increased urobilinogen in urine, which can be detected by Ehrlich's test <a class="yt-timestamp" data-t="00:22:57">[00:22:57]</a>.
*   **Answer:** Direct bilirubin normal, indirect bilirubin increased, urine urobilinogen increased <a class="yt-timestamp" data-t="00:23:30">[00:23:30]</a>.

### Glycine Titration Curve and Isoelectric Point (pI)
The question asked for the zwitterionic pH of glycine from its titration curve <a class="yt-timestamp" data-t="00:23:39">[00:23:39]</a>.
*   **Zwitterionic pH:** This refers to the isoelectric point (pI), the pH at which a compound exists as a zwitterion or ampholyte <a class="yt-timestamp" data-t="00:24:01">[00:24:01]</a>.
*   **Calculation:** pI is the average of the two ionization constants (PK1 and PK2) <a class="yt-timestamp" data-t="00:24:15">[00:24:15]</a>.
    *   Given PK1 = 2.4 and PK2 = 9.8 <a class="yt-timestamp" data-t="00:24:35">[00:24:35]</a>.
    *   pI = (2.4 + 9.8) / 2 = 12.2 / 2 = 6.1 <a class="yt-timestamp" data-t="00:24:46">[00:24:46]</a>.
*   **Note for amino acids with three ionizable groups (e.g., aspartic acid):** pI is the average of the ionization constants of the *isoionic species* (i.e., the two pK values closest to the neutral form, typically ignoring the alpha-amino group's pK if there's a side chain pK of similar acidity/basicity) <a class="yt-timestamp" data-t="00:25:48">[00:25:48]</a>. For aspartic acid, it would be (PK2 + PK3) / 2 <a class="yt-timestamp" data-t="00:26:15">[00:26:15]</a>.
*   **Answer:** 6 (or 6.1) <a class="yt-timestamp" data-t="00:25:00">[00:25:00]</a>.

### Cyanide and Carbon Monoxide Action
This question asked which hemoprotein cyanide and carbon monoxide act on <a class="yt-timestamp" data-t="00:26:31">[00:26:31]</a>.
*   **Mechanism:** Both cyanide and carbon monoxide inhibit Complex IV (cytochrome c oxidase) of the electron transport chain <a class="yt-timestamp" data-t="00:26:37">[00:26:37]</a>.
*   **Answer:** Cytochrome C oxidase <a class="yt-timestamp" data-t="00:26:44">[00:26:44]</a>.

### Glucose Consumption in Cancer Cells
The question asked why cancer cells consume more glucose <a class="yt-timestamp" data-t="00:26:49">[00:26:49]</a>.
*   **Warburg Effect/Aerobic Glycolysis:** Cancer cells convert glucose to lactate even in the presence of oxygen, a process called aerobic glycolysis <a class="yt-timestamp" data-t="00:27:00">[00:27:00]</a> <a class="yt-timestamp" data-t="00:27:05">[00:27:05]</a>. This yields only 2 ATPs per glucose molecule <a class="yt-timestamp" data-t="00:27:20">[00:27:20]</a>.
*   **Reason for Increased Consumption:** Due to the low ATP yield, cancer cells must take up more glucose to meet their energy demands <a class="yt-timestamp" data-t="00:27:50">[00:27:50]</a>.
*   **Underlying Mechanism (Metabolic Reprogramming):** This phenomenon is largely due to "metabolic reprogramming," specifically the presence of the PKM2 isoform of pyruvate kinase in cancer cells, instead of the usual PKM1 isoform <a class="yt-timestamp" data-t="00:28:42">[00:28:42]</a> <a class="yt-timestamp" data-t="00:28:52">[00:28:52]</a>.
*   **Answer:** Increased lactate production even in the presence of oxygen <a class="yt-timestamp" data-t="00:27:56">[00:27:56]</a>.

### Genetic Testing for Breast and Ovarian Cancer
A 30-year-old female with a strong family history of breast and ovarian cancer was referred for genetic testing <a class="yt-timestamp" data-t="00:29:19">[00:29:19]</a>. The question asked for the single best genetic test.
*   **Gene:** Familial breast and ovarian cancer is commonly associated with BRCA1 and BRCA2 mutations <a class="yt-timestamp" data-t="00:29:30">[00:29:30]</a>. These are typically point mutations or small mutations <a class="yt-timestamp" data-t="00:30:00">[00:30:00]</a> <a class="yt-timestamp" data-t="00:30:20">[00:30:20]</a>.
*   **Technique Selection:** The best technique depends on the type of mutation suspected <a class="yt-timestamp" data-t="00:31:36">[00:31:36]</a>.
    *   **qPCR (Quantitative PCR):** Used for mutations affecting length or gene dosage (e.g., trinucleotide repeats, large gene deletions) <a class="yt-timestamp" data-t="00:31:01">[00:31:01]</a>. Not ideal for point mutations <a class="yt-timestamp" data-t="00:31:42">[00:31:42]</a>.
    *   **RT-PCR (Reverse Transcriptase PCR):** Used for gene expression studies (RNA levels), not DNA mutations <a class="yt-timestamp" data-t="00:32:02">[00:32:02]</a>.
    *   **Southern Blotting:** Can be used for DNA hybridization, but not the single best method for this type of mutation <a class="yt-timestamp" data-t="00:32:31">[00:32:31]</a>.
    *   **Next-Generation Sequencing (NGS):** Includes Whole Genome Sequencing (WGS) and Whole Exome Sequencing (WES). WES sequences only the coding regions (exons), making it more cost-effective than WGS while still comprehensive <a class="yt-timestamp" data-t="00:33:03">[00:33:03]</a> <a class="yt-timestamp" data-t="00:33:43">[00:33:43]</a>.
*   **Answer:** Exome sequencing <a class="yt-timestamp" data-t="00:31:54">[00:31:54]</a> <a class="yt-timestamp" data-t="00:33:46">[00:33:46]</a>.

### "Eye of Tiger Sign" and Pantothenate Kinase Deficiency
A 12-year-old boy presented with rigidity, cognitive impairment, and an MRI showing a "tiger eye sign" <a class="yt-timestamp" data-t="00:33:50">[00:33:50]</a>.
*   **Biochemical Relation:** This sign is associated with a defect in pantothenate (Vitamin B5) utilization <a class="yt-timestamp" data-t="00:34:13">[00:34:13]</a>.
*   **Condition:** This is Pantothenate Kinase-Associated Neurodegeneration (PKAN), also known as Hallervorden–Spatz syndrome <a class="yt-timestamp" data-t="00:34:26">[00:34:26]</a>. It is a neurodegenerative disorder with symptoms like chorea, dystonia, and Parkinsonian features <a class="yt-timestamp" data-t="00:34:40">[00:34:40]</a>.
*   **Answer:** Pantothenate kinase deficiency (PKAN) <a class="yt-timestamp" data-t="00:34:26">[00:34:26]</a>.

### Glucose Uptake in Uncontrolled Diabetes
In uncontrolled diabetes, the question asked in which cell there is decreased glucose uptake <a class="yt-timestamp" data-t="00:35:07">[00:35:07]</a>.
*   **Insulin-Dependent Glucose Transporters:** Glucose uptake is reduced in cells that rely on insulin-dependent glucose transporters (GLUT4) when insulin is deficient <a class="yt-timestamp" data-t="00:35:39">[00:35:39]</a>.
*   **Locations:** These transporters are primarily present in heart, skeletal muscle, and adipose tissue <a class="yt-timestamp" data-t="00:35:31">[00:35:31]</a>.
*   **Answer:** Skeletal muscle <a class="yt-timestamp" data-t="00:35:47">[00:35:47]</a>.

### Identifying Mutated Strains of *Mycobacterium tuberculosis*
The question asked which methods are used to identify different mutated strains of the same species of *Mycobacterium tuberculosis* (multiple response) <a class="yt-timestamp" data-t="00:35:52">[00:35:52]</a>.
*   **Genotyping Goal:** To identify changes or mutations in the DNA sequence of the bacteria <a class="yt-timestamp" data-t="00:36:08">[00:36:08]</a>.
*   **Techniques:**
    *   **Chromosome mutation analysis:** A general term for techniques that detect changes in the DNA <a class="yt-timestamp" data-t="00:37:00">[00:37:00]</a>.
    *   **RFLP (Restriction Fragment Length Polymorphism):** An older but still popular technique where restriction enzymes cut DNA at specific sites. Mutations in these sites alter fragment lengths, allowing strain identification <a class="yt-timestamp" data-t="00:37:05">[00:37:05]</a>.
    *   **Spoligotyping:** Targets unique spacer sequences located on either side of direct repeats in the *Mycobacterium tuberculosis* genome <a class="yt-timestamp" data-t="00:37:46">[00:37:46]</a>.
    *   **MIRU-VNTR (Multiple Interspersed Repetitive Unit-Variable Number Tandem Repeat) Typing:** A more advanced technique that directly analyzes variable number tandem repeats (VNTRs) in the genome, offering higher discriminatory quality than spoligotyping <a class="yt-timestamp" data-t="00:38:28">[00:38:28]</a>.
    *   **Next-Generation Sequencing (NGS):** Such as Whole Genome Sequencing (WGS), which can definitively identify different bacterial strains <a class="yt-timestamp" data-t="00:39:17">[00:39:17]</a>.
*   **Answer:** RFLP, Chromosome mutation analysis, Spoligotyping, and MIRU-VNTR <a class="yt-timestamp" data-t="00:39:32">[00:39:32]</a>.

### Surface Plasmon Resonance (SPR) Graph Interpretation
An SPR graph was given, and the question asked what it represents <a class="yt-timestamp" data-t="00:39:47">[00:39:47]</a>. This was considered a difficult question <a class="yt-timestamp" data-t="00:39:44">[00:39:44]</a>.

*   **Key Features of SPR:**
    *   **Real-time measurement:** SPR monitors antigen-antibody binding as it happens, unlike ELISA which is an endpoint assay <a class="yt-timestamp" data-t="00:41:13">[00:41:13]</a> <a class="yt-timestamp" data-t="00:41:17">[00:41:17]</a>.
    *   **Label-free technique:** It does not require a secondary labeled antibody or reporter molecule <a class="yt-timestamp" data-t="00:44:53">[00:44:53]</a>.
    *   **Detection Principle:** When antigen-antibody complexes form on a sensor surface, they produce plasmon waves, altering a measurable angle (surface plasmon resonance angle) <a class="yt-timestamp" data-t="00:41:55">[00:41:55]</a> <a class="yt-timestamp" data-t="00:42:03">[00:42:03]</a>.
    *   **Graph Interpretation:** The curve shows an ascent during association (binding) of antigen and antibody, plateauing when complexes form, and then a regression during dissociation <a class="yt-timestamp" data-t="00:42:29">[00:42:29]</a>.
*   **Application:** SPR is considered a gold standard method to determine antibody affinity (how strongly an antibody binds to its antigen) <a class="yt-timestamp" data-t="00:43:45">[00:43:45]</a> <a class="yt-timestamp" data-t="00:45:28">[00:45:28]</a>. It does not measure antibody concentration directly <a class="yt-timestamp" data-t="00:44:25">[00:44:25]</a>.
*   **Answer:** Real-time Surface Plasmon Resonance (SPR) for antibody affinity <a class="yt-timestamp" data-t="00:43:45">[00:43:45]</a>.